Cargando…
PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429483/ http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8 |
_version_ | 1785090725232246784 |
---|---|
author | Charef, Ons Mlayah, Zaineb Bnouni, Yasmine Mabrouk, Nada Boufrikha, Wiem Nader, Slama Boukhriss, Sarra Laatiri, Adnene |
author_facet | Charef, Ons Mlayah, Zaineb Bnouni, Yasmine Mabrouk, Nada Boufrikha, Wiem Nader, Slama Boukhriss, Sarra Laatiri, Adnene |
author_sort | Charef, Ons |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104294832023-08-17 PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA Charef, Ons Mlayah, Zaineb Bnouni, Yasmine Mabrouk, Nada Boufrikha, Wiem Nader, Slama Boukhriss, Sarra Laatiri, Adnene Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429483/ http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Charef, Ons Mlayah, Zaineb Bnouni, Yasmine Mabrouk, Nada Boufrikha, Wiem Nader, Slama Boukhriss, Sarra Laatiri, Adnene PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title | PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title_full | PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title_fullStr | PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title_full_unstemmed | PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title_short | PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA |
title_sort | pb2342: prognostic significance of pretreatment neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index in patients with diffuse large b-cell lymphoma |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429483/ http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8 |
work_keys_str_mv | AT charefons pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT mlayahzaineb pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT bnouniyasmine pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT mabrouknada pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT boufrikhawiem pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT naderslama pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT boukhrisssarra pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma AT laatiriadnene pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma |